BDBM561499 US11390631, Example 41::US11390631, Example 42::US12268694, Example 41

SMILES O=C1Nc2ccccc2C(=NC1Nc1nnc(o1)-c1ccc2nc[nH]c2c1)c1ccccc1

InChI Key InChIKey=MWSMOFDMSYGSJG-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 561499   

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561499(US11390631, Example 41 | US11390631, Example 42 | ...)
Affinity DataEC50: >800nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561499(US11390631, Example 41 | US11390631, Example 42 | ...)
Affinity DataEC50:  600nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561499(US11390631, Example 41 | US11390631, Example 42 | ...)
Affinity DataEC50: >800nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent